Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ESCMID COVID-19 living guidelines: drug treatment and clinical management.
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Paño-Pardo JR, Power NR, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Zollner-Schwetz I, Rodríguez-Baño J. Bartoletti M, et al. Among authors: szabo bg. Clin Microbiol Infect. 2022 Feb;28(2):222-238. doi: 10.1016/j.cmi.2021.11.007. Epub 2021 Nov 22. Clin Microbiol Infect. 2022. PMID: 34823008 Free PMC article.
ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply.
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Martín-Quirós A, Paño-Pardo JR, Power N, Sibani M, Szabo B, Tsiodras S, Zollner-Schwetz I, Rodriguez-Baño J; ESCMID COVID-19 Treatment Guidelines Panel. Bartoletti M, et al. Clin Microbiol Infect. 2022 Apr;28(4):617-618. doi: 10.1016/j.cmi.2021.12.025. Epub 2022 Jan 10. Clin Microbiol Infect. 2022. PMID: 35026374 Free PMC article. No abstract available.
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!
Barac A, Bartoletti M, Azap O, Bussini L, Ergonul O, Krause R, Paño-Pardo JR, Power NR, Rodríguez-Baño J, Sibani M, Szabo BG, Tsiodras S, Verweij PE, Quirós AM, Zollner-Schwetz I. Barac A, et al. Among authors: szabo bg. Clin Microbiol Infect. 2022 Jul;28(7):908-910. doi: 10.1016/j.cmi.2022.03.022. Epub 2022 Mar 23. Clin Microbiol Infect. 2022. PMID: 35337977 Free PMC article. No abstract available.
European society of clinical microbiology and infectious diseases guidelines for coronavirus disease 2019: an update on treatment of patients with mild/moderate disease.
Bartoletti M, Azap O, Barac A, Bussini L, Ergonul O, Krause R, Martin-Quiros A, Paño-Pardo JR, Power N, Sibani M, Szabo BG, Tsiodras S, Zollner-Schwetz I, Rodríguez-Baño J. Bartoletti M, et al. Among authors: szabo bg. Clin Microbiol Infect. 2022 Dec;28(12):1578-1590. doi: 10.1016/j.cmi.2022.08.013. Epub 2022 Aug 24. Clin Microbiol Infect. 2022. PMID: 36028088 Free PMC article.
A novel id-iri score: development and internal validation of the multivariable community acquired sepsis clinical risk prediction model.
Diktas H, Uysal S, Erdem H, Cag Y, Miftode E, Durmus G, Ulu-Kilic A, Alabay S, Szabo BG, Lakatos B, Fernandez R, Korkmaz P, Caliz MC, Argemi X, Kulzhanova S, Kormaz F, Yilmaz-Karadag F, Ergen P, Atilla A, Puca E, Dogan M, Mangani F, Sahin S, Grgić S, Grozdanovski K, Yilmaz GR, Del-Vecchio RF, Demirel A, Sirmatel F, Şener A, Sacar S, Aydin E, Batirel A, Dragovac G, El-Sokkary R, Alexandru C, Arslan-Ozel S, Bolukcu S, Ozkaya HD, Nayman-Alpat S, Inan A, Al-Majid F, Kaya-Ugur B, Rello J. Diktas H, et al. Among authors: szabo bg. Eur J Clin Microbiol Infect Dis. 2020 Apr;39(4):689-701. doi: 10.1007/s10096-019-03781-y. Epub 2019 Dec 10. Eur J Clin Microbiol Infect Dis. 2020. PMID: 31823148
Characteristics and predictors of treatment failure with intravenous tigecycline monotherapy among adult patients with severe Clostridioides (Clostridium) difficile infection: a single-centre observational cohort study.
Szabo BG, Duma L, Lenart KS, Kiss R, Vad E, Petrik BR, Ostorhazi E, Kadar B. Szabo BG, et al. Diagn Microbiol Infect Dis. 2021 Feb;99(2):115231. doi: 10.1016/j.diagmicrobio.2020.115231. Epub 2020 Oct 6. Diagn Microbiol Infect Dis. 2021. PMID: 33099134
Favipiravir treatment does not influence disease progression among adult patients hospitalized with moderate-to-severe COVID-19: a prospective, sequential cohort study from Hungary.
Szabo BG, Lenart KS, Petrik B, Gaspar Z, Kiss-Dala N, Szlavik J, Valyi-Nagy I, Lakatos B; Saint Ladislaus COVID-19 Collaborative. Szabo BG, et al. Geroscience. 2021 Oct;43(5):2205-2213. doi: 10.1007/s11357-021-00452-9. Epub 2021 Sep 3. Geroscience. 2021. PMID: 34476717 Free PMC article.
115 results